Safeway was awarded the E. Donnall Thomas Medal of Achievement Medal
On Oct. 9, 2007, the Fred Hutchinson Business Alliance announced that the 2007 E. Donnall Thomas Medal of…
The Stanford Cancer Institute became a NCI Designated Cancer Center
On Sept. 23, 2007, the Stanford Cancer Institute (SCI) was awarded “cancer center” designation from the National Cancer…
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved Eli Lilly and Company’s osteoporosis drug, Evista, to reduce the risk of invasive breast cancer
On Sept. 14, 2007, the U.S. Food and Drug Administration (FDA) announced it had approved Eli Lilly’s osteoporosis…
Winship Cancer Institute received a 5-year, $12.5 million SPORE grant in head and neck cancer
On Sept. 10, 2007, the National Cancer Institute (NCI) awarded a five-year, $12.5 million Specialized Program of Research…
Researchers from the Hutchinson Center and Seattle Children’s developed a “tumor paint” that illuminates cancerous cells
On Jul. 15, 2007, Dr. Jim Olson and colleagues from Fred Hutchinson Cancer Research Center and Seattle Children’s…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
National Cancer Institute launched pilot of its Community Cancer Centers program
On Jun. 14, 2007, the National Cancer Institute (NCI) launched the 3-year pilot phase of a new program…
The University of New Mexico Cancer Center broke ground on new state-of-the-art cancer treatment and research facility
On May 15, 2007, the University of New Mexico Cancer Center broke ground on new state-of-the-art cancer treatment…
National Cancer Institute reported risk of lymphoma increases with Hepatitis C virus infection
On May 8, 2007, the National Cancer Institute (NCI) reported that people infected with the hepatitis C virus…
National Breast and Cervical Cancer Act allowed states federal waivers to spend a greater share of funds on underserved women
On Apr. 20, 2007, the National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 allowed…
Biotechnology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
Decrease in breast cancer rates related to reduction in use of hormone replacement therapy
On Apr. 18, 2007, a study led by the University of Texas M.D. Anderson Cancer Center reported that…
Biotechnology | Diagnostics | Disease | Genomics | Oncology
National Cancer Institute researchers discovered common variation in a gene segment that increases risk for prostate cancer
On Apr. 1, 2007, National Cancer Institute (NCI) researchers reported that a variation in a portion of DNA…
MRI detected cancers in the opposite breast of women newly diagnosed with breast cancer
On Mar. 28, 2007, Magnetic Resonance Imaging (MRI) scans of women who were diagnosed with cancer in one…
OHSU received $40 million donation from an anonymous donor
On Feb. 8, 2007, Oregon Health & Science University (OHSU) and the OHSU Foundation announced the largest outright gift…
Phase III clinical trial showed patients treated with arsenic trioxide had better overall survival than patients who received chemotherapy alone
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
National Cancer Control Month created by U.S. Congress
In 2007, the U.S. Congress declared May National Cancer Control Month, an opportunity to educate all Americans about…
The St Jude LIFE study on long-term effects of cancer and its treatment launched
In 2007, The St. Jude LIFE study on the long-term effects of cancer and its treatment began. This…
The Cancer Prevention and Research Institute of Texas was founded
In 2007, Texans voted to create the Cancer Prevention & Research Institute of Texas (CPRIT) and to invest…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
The National Cancer Institute released preliminary data on genetic susceptibility for prostate cancer
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics | Women's Health
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
The OMRF celebrated it’s 60th anniversary
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
John E. Niederhuber became the thirteenth director of the National Cancer Institute
On Sept. 1, 2006, President Bush appointed John E. Niederhuber, M.D., to be the 13th director of the…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
Alaska Airlines awarded E. Donnall Thomas Medal of Achievement Medal
On Jul. 18, 2006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
Gene expression profiling can accurately diagnose Burkitt’s lymphoma
On Jun. 7, 2006, gene profiling, a molecular technique that examines many genes simultaneously, can accurately distinguish between…
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…